TY - JOUR
T1 - Two cases of primary adult T-cell leukemia/lymphoma of bone
T2 - case reports and a review of the literature
AU - Kuriyama, Takuro
AU - Kawano, Noriaki
AU - Yamashita, Kiyoshi
AU - Kikuchi, Ikuo
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Primary bone lymphomas comprise <1 % of all malignant lymphomas, and there have been only a limited number of reports on primary adult T-cell leukemia/lymphoma (ATLL) of bone. Here, we report two cases of primary ATLL of bone. The first case was a 41-year-old woman with multiple bone tumors. She was diagnosed with ATLL of the skull through biopsy and treated with chemotherapy. Although the bone lesions showed transient improvement, the subsequent central nervous system (CNS) invasion of ATLL occurred and she died 7 months after diagnosis. The second case was a 65-year-old man with right coxodynia. He was diagnosed with ATLL through right femoral biopsy, and the lesion improved with chemotherapy. However, CNS invasion of ATLL developed during chemotherapy, and he died 10 months after diagnosis. Both the patients with primary ATLL of the bone reported here experienced CNS invasion. Thus, ATLL treatment should aim to prevent CNS invasion at an early stage.
AB - Primary bone lymphomas comprise <1 % of all malignant lymphomas, and there have been only a limited number of reports on primary adult T-cell leukemia/lymphoma (ATLL) of bone. Here, we report two cases of primary ATLL of bone. The first case was a 41-year-old woman with multiple bone tumors. She was diagnosed with ATLL of the skull through biopsy and treated with chemotherapy. Although the bone lesions showed transient improvement, the subsequent central nervous system (CNS) invasion of ATLL occurred and she died 7 months after diagnosis. The second case was a 65-year-old man with right coxodynia. He was diagnosed with ATLL through right femoral biopsy, and the lesion improved with chemotherapy. However, CNS invasion of ATLL developed during chemotherapy, and he died 10 months after diagnosis. Both the patients with primary ATLL of the bone reported here experienced CNS invasion. Thus, ATLL treatment should aim to prevent CNS invasion at an early stage.
UR - http://www.scopus.com/inward/record.url?scp=84965006883&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965006883&partnerID=8YFLogxK
U2 - 10.1007/s12185-016-2015-1
DO - 10.1007/s12185-016-2015-1
M3 - Article
C2 - 27145781
AN - SCOPUS:84965006883
SN - 0925-5710
VL - 104
SP - 392
EP - 395
JO - International Journal of Hematology
JF - International Journal of Hematology
IS - 3
ER -